Don't miss the chance to connect with specific demographics within the child and adolescent psychiatry community in 2017!
Tabletop exhibits are available at each of our annual institutes and are placed in high-traffic areas near the coffee break or an area directly adjacent to the meeting room, providing exhibitors with the greatest opportunity to meet attendees. The vast majority of our attendees are practicing physicians.
Exhibit opportunities are as follows:
2017 Pediatric Psychopharmacology Update Institute
Psychopharmacology Treatments From
Childhood Through Transitional Age
Co-Chairs: Gabrielle A. Carlson, MD, and Manpreet Kaur Singh, MD, MS
The Westin St. Francis San Francisco on Union Square
San Francisco, CA
January 20-21, 20017
Expected Attendance: 550
AACAP’s 2017 Pediatric Psychopharmacology Update Institute, Psychopharmacology Treatments from Childhood Through Transitional Age, links in these age groups the latest findings on the treatment of attention-deficit/hyperactivity disorder (ADHD), bipolar and depressive disorders, eating disorders, psychosis and schizophrenia, autism spectrum disorders, pediatric autoimmune neuropsychiatric disorders (PANS and PANDAS), and prodromal and high-risk mood and psychotic disorders.
Eight top child and adolescent psychiatric researchers detail their approaches to treatment of psychiatric disorders from preschool through transitional age youth with the latest psychiatric medications, discussing medication selection, effectiveness, and expected adverse events. They review the latest data that address the balance of benefit to risk across this age range using first-line psychotropic medications, in the treatment of youth. In addition to known best evidence, including FDA-approved treatments, the speakers describe other relevant treatments that work in conjunction with psychotropic medication.
At the end of the Institute, clinicians will have thoroughly reviewed current publications on psychopharmacologic treatments across the age range targeted so they can discuss how efficacy, safety, and outcome data is translated into clinical practice.
Douglas B. Hansen, MD, 42nd Annual Review Course in Child and Adolescent Psychiatry
Co-Chairs: Gabrielle A. Carlson, MD and Mary Margaret Gleason, MD
Royal Sonesta New Orleans
New Orleans, LA
March 18-20, 2017
Expected Attendance: 150-200
AACAP’s Douglas B. Hansen, MD, 42nd Annual Review Course emphasizes the most recent material relevant to the general practice of child and adolescent psychiatry and serves as an up-to-date review of child and adolescent psychiatry as well as addresses important clinical research. The course is designed to update practitioners on state-of-the-art standards of diagnosis and treatment.
Download a copy of the AACAP Tabletop Exhibit Application Form.
The Invitation to Exhibit for our 64th Annual Meeting, October 23-28, 2017, at the Marriott Wardman Park and Omni Shore Hotels will be mailed in May 2017.
For more information, please contact:
AACAP Meetings and Exhibits Manager